Peptides whose uptake by cells is controllable

Details Peptides whose uptake by cells is controllable Peptides whose uptake by cells is controllable

2011-07-26

2011-07-26

Jones, D. L (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S001110, C424S001650, C424S009600, C530S328000

Reexamination Certificate

active

07985401

ABSTRACT:
A generic structure for the peptides of the present invention includes A-X-B-C, where C is a cargo moiety, the B portion includes basic amino acids, X is a cleavable linker sequence, and the A portion includes acidic amino acids. The intact structure is not significantly taken up by cells; however, upon extracellular cleavage of X, the B-C portion is taken up, delivering the cargo to targeted cells. Cargo may be, for example, a contrast agent for diagnostic imaging, a chemotherapeutic drug, or a radiation-sensitizer for therapy. X may be cleaved extracellularly or intracellularly. The molecules of the present invention may be linear, cyclic, branched, or have a mixed structure.

REFERENCES:
patent: 4466919 (1984-08-01), Weingarten
patent: 4507389 (1985-03-01), Weingarten
patent: 5674980 (1997-10-01), Frankel et al.
patent: 5747641 (1998-05-01), Frankel et al.
patent: 6348185 (2002-02-01), Piwnica-Worms
patent: 7431915 (2008-10-01), Jiang et al.
patent: 2003/0176335 (2003-09-01), Zhang et al.
patent: 2005/0107583 (2005-05-01), Jiang et al.
patent: 2006/0041105 (2006-02-01), Jiang et al.
patent: WO 01/75067 (2001-10-01), None
patent: WO 2005/042034 (2005-05-01), None
Bartles et al (1996), Journal of Cell Science, vol. 109, No. 6, pp. 1229-1239.
Golub, T.R. et al. “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring,” Science, 1999, vol. 286, pp. 531-537.
Ullrich, K.J. et al., “Contraluminal para-aminohippurate (PAH) transport in the proximal tubule of the rat kidney,” Pflügers Arch, 1989, vol. 415, pp. 342-350.
Bhorade, R. et al., “Macrocyclic Chelators with Paramagnetic Cations Are Internalized into Mammalian Cells via a HIV-Tat Derived Membrane Translocation Peptide,”Bioconjugate Chemistry, May/Jun. 2000, pp. 301-305, vol. 11, No. 3.
European Supplementary Search Report mailed on Feb. 15, 2011, for EP Application No. 04817443.7, 3 pages.
European Supplementary Search Report mailed on Apr. 12, 2011, for EP Application No. 06760150.0, 4 pages.
Jiang, T. et al., “Tumor imaging by means of proteolytic activation of cell-penetrating peptides,”PNAS, Dec. 21, 2004, pp. 17867-17872, vol. 101, No. 51.
Wang, Y. et al., “Visualizing the mechanical activation of Src,”Nature, Apr. 21, 2005, pp. 1040-1045, vol. 434.

Affiliated with

Also associated with

Rating

Peptides whose uptake by cells is controllable does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides whose uptake by cells is controllable, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides whose uptake by cells is controllable will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2634805